NAV2/24/2017 Chg.+2.2300 Type of yield Investment Focus Investment company
522.0700EUR +0.43% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.57 6.12 6.42 -1.06 3.16 -11.73 4.92 5.03 -
2010 4.64 4.78 5.80 0.08 -5.05 -3.26 -3.14 0.42 4.28 4.50 1.74 4.27 +19.88%
2011 -5.00 -0.58 -1.77 3.43 3.21 -1.63 -1.22 -13.48 -0.20 1.92 4.02 6.76 -5.94%
2012 12.44 -0.50 3.77 0.96 6.42 1.08 6.96 -0.39 3.53 -9.25 4.57 -1.92 +29.46%
2013 4.41 5.53 9.71 6.48 4.70 -4.20 12.28 -2.09 6.27 -3.63 8.04 -0.23 +56.68%
2014 12.36 4.08 -10.71 -4.63 4.48 8.14 1.15 13.08 3.01 11.02 3.10 2.31 +55.24%
2015 15.70 6.35 4.96 -7.88 12.24 -2.01 2.87 -12.82 -12.03 10.61 7.05 -1.90 +19.90%
2016 -22.80 -5.60 -0.37 3.47 6.31 -9.21 12.44 -2.44 1.99 -11.88 12.34 -3.40 -22.44%
2017 4.88 6.59 - - - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 20.50% 28.32% 28.88% 30.79% 27.04%
Sharpe ratio 5.80 0.62 0.67 0.34 0.90
Best month +6.59% +12.34% +12.44% +15.70% +15.70%
Worst month -3.40% -11.88% -11.88% -22.80% -22.80%
Maximum loss -7.21% -19.55% -19.95% -44.38% -44.38%
Outperformance +4.99% - +3.55% -5.02% +61.92%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 438.5100 +15.01% +5.14%
BB Adamant Biotech I EUR reinvestment 555.6900 +19.93% +36.55%
BB Adamant Biotech I CHF reinvestment 389.0900 +17.23% +18.96%
BB Adamant Biotech I GBP reinvestment 370.9400 - -
BB Adamant Biotech B USD reinvestment 413.5200 +14.16% +2.82%
BB Adamant Biotech B CHF reinvestment 364.9400 +16.36% +16.34%
BB Adamant Biotech B EUR reinvestment 522.0700 +19.05% +33.54%

Performance

YTD  
+11.79%
6 Months  
+8.32%
1 Year  
+19.05%
3 Years  
+33.54%
5 Years  
+192.66%
Since start  
+317.66%
Year
2016
  -22.44%
2015  
+19.90%
2014  
+55.24%
2013  
+56.68%
2012  
+29.46%
2011
  -5.94%
2010  
+19.88%